Li Nana, Jia Haitao, Liu Zhen, Tao Jing, Chen Song, Li Xiaohong, Deng Ying, Jin Xi, Song Jiaping, Zhang Liangtao, Liang Yu, Wang Wei, Zhu Jun
National Center for Birth Defect Monitoring, West China Second University Hospital, Sichuan University, Sec. 3 No. 20, South RenMin Road, Chengdu, Sichuan, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Sec. 3 No. 20, South RenMin Road, Chengdu, Sichuan, China.
Sci Rep. 2015 Oct 27;5:15769. doi: 10.1038/srep15769.
Phenylketonuria (PKU) is an inherited autosomal recessive disorder of phenylalanine metabolism, mainly caused by a deficiency of phenylalanine hydroxylase (PAH). The incidence of various PAH mutations differs among race and ethnicity. Here we report a spectrum of PAH mutations complied from 796 PKU patients from mainland China. The all 13 exons and adjacent intronic regions of the PAH gene were determined by next-generation sequencing. We identified 194 different mutations, of which 41 are not reported before. Several mutations reoccurred with high frequency including p.R243Q, p.EX6-96A > G, p.V399V, p.R241C, p.R111*, p.Y356*, p.R413P, and IVS4-1G > A. 76.33% of mutations were localized in exons 3, 6, 7, 11, 12. We further compared the frequency of each mutation between populations in northern and southern China, and found significant differences in 19 mutations. Furthermore, we identified 101 mutations that are not reported before in Chinese population, our study thus broadens the mutational spectrum of Chinese PKU patients. Additionally, 41 novel mutations will expand and improve PAH mutation database. Finally, our study offers proof that NGS is effective, reduces screening times and costs, and facilitates the provision of appropriate genetic counseling for PKU patients.
苯丙酮尿症(PKU)是一种苯丙氨酸代谢的常染色体隐性遗传疾病,主要由苯丙氨酸羟化酶(PAH)缺乏引起。不同PAH突变的发生率在不同种族和民族中有所差异。在此,我们报告了来自中国大陆796例PKU患者的一系列PAH突变情况。通过下一代测序确定了PAH基因的全部13个外显子和相邻内含子区域。我们鉴定出194种不同的突变,其中41种此前未被报道。有几种突变高频出现,包括p.R243Q、p.EX6-96A>G、p.V399V、p.R241C、p.R111*、p.Y356*、p.R413P和IVS4-1G>A。76.33%的突变位于外显子3、6、7、11、12。我们进一步比较了中国北方和南方人群中每种突变的频率,发现19种突变存在显著差异。此外,我们鉴定出101种在中国人群中此前未被报道的突变,因此我们的研究拓宽了中国PKU患者的突变谱。此外,41种新突变将扩展和完善PAH突变数据库。最后,我们的研究证明了二代测序是有效的,减少了筛查时间和成本,并有助于为PKU患者提供适当的遗传咨询。